Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENVAD-HF: Sacubitril/Valsartan in HeartMate 3 LVAD Recipients
NCT04103554Phase 4Active, not recruiting
- Sponsor
- University of Zagreb
- Start
- Feb 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), sponsored by University of Zagreb. Started Feb 2021; status: active, not recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04103554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04103554.